Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
22 November 2022
Closing Date:
16 January 2023
Location(s):
BE256 Arr. Roeselare (BE Belgium/BELGIQUE-BELGIË)
Description:
Antibiotics

This contract shall include the conclusion of a framework agreement for the supply of antibiotics for a period of one year and tacitly renewable three times for one year at a time.

Amoxicillin powder v suspension 250 mg/5 ml 100 ml

See II.2.1

Clarithromycine co

See II.2.1

Clindamycine caps

See II.2.1

Doxycycline deelbare co

See II.2.1

Flucloxacilline caps

See II.2.1

Levofloxacine tablet

See II.2.1

Minocycline tablet

See II.2.1

Moxifloxacine co

See II.2.1

Sulfamethoxazole + Trimethoprim Tablet

See II.2.1

Linezolid co

See II.2.1

AMIKACIN IV

See II.2.1

Amoxicillin powder v suspension 500 mg/5 ml 100 ml

See II.2.1

Amoxicillin + Clavulanic Acid IV

See II.2.1

Benzylpenicilline IV

See II.2.1

Cefazoline IV

See II.2.1

Ceftazidime IV

See II.2.1

Ceftriaxone IV

See II.2.1

CEFUROXIME IV

See II.2.1

Ciprofloxacin IV

See II.2.1

Clindamycin IV

See II.2.1

FLUCLOXACILLIN IV

See II.2.1

Levofloxacin IV

See II.2.1

Amoxicillin + clavulanic acid powder v suspension

See II.2.1

Linezolid IV

See II.2.1

Meropenem IV

See II.2.1

Moxifloxacin IV

See II.2.1

Piperacillin + Tazobactam IV

See II.2.1

Vancomycin IV

See II.2.1

Azithromycin powder v suspension

See II.2.1

Clarithromycin powder v suspension

See II.2.1

Amoxicillin (+ clavulaanzuur) co

See II.2.1

Azithromycine co

See II.2.1

Cefuroxime tablet

See II.2.1

Ciprofloxacin Tablet

See II.2.1

Download full details as .pdf
The Buyer:
AZ Delta vzw
CPV Code(s):
33600000 - Pharmaceutical products
33631400 - Antibiotics and chemotherapeutics for dermatological use